Ibrance 125 MG tablet 7S
Ended Awarded
- Contract number
- SPE2DX25F6UHX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $32,472
Award facts
- Contract value 100% obligated
- $32,472.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ibrance 125 mg tablets in a quantity of 7 units, with a contract ceiling value of $32,472.32. This competitive delivery order, which carries a firm fixed price structure and is not subject to a set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026) with the Defense Logistics Agency Troop Support Medical that serves as the overarching vehicle supporting this delivery order.
This delivery order represents a continuation of AmerisourceBergen's role as a critical federal medical procurement vendor, supplying brand-name and generic pharmaceutical products to support military and veteran healthcare systems. Ibrance (palbociclib) is a prescription cancer medication used in the treatment of certain types of breast cancer. The award demonstrates the contractor's ongoing capability to meet federal procurement requirements for specialized pharmaceutical commodities through competitive processes, consistent with the Defense Logistics Agency's pharmaceutical prime vendor model that supports the Defense Health Agency and other government healthcare customers globally.
Quick answers
Who was awarded contract SPE2DX25F6UHX?
SPE2DX25F6UHX was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 3, 2025.
How much is contract SPE2DX25F6UHX worth?
The government has obligated $32,472 on SPE2DX25F6UHX.
Is contract SPE2DX25F6UHX an order under another contract?
Yes. SPE2DX25F6UHX is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6UHX competed?
The extent of competition for SPE2DX25F6UHX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award